Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. It operates through the following segments: Regenerative Medicine, Custom Development and Manufacturing, and Research and Development (R&D) Support. The Regenerative Medicine segment develops, manufactures, and sells tissue-engineered medical products through autologous culturing techniques. The Custom Development and Manufacturing segment consists of research and development, clinical development, regulatory affairs, production, quality assurance, and sales of regenerative medical products. The R&D Support segment deals with the research of cultured human tissues. The company was founded on February 1, 1999 and is headquartered in Gamagori, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company